期刊文献+

北京水利医院2018年依替米星专项处方点评分析 被引量:3

The analysis of etimicin specific prescription in 2018 from Beijing Water Conservancy Hospital
原文传递
导出
摘要 目的通过处方点评,促进依替米星临床合理用药。方法通过对北京水利医院2018年1—10月门急诊依替米星处方进行专项点评,分析临床用药合理性。结果使用依替米星处方共计729张,其中不合理处方508张,处方不合格率69.68%。主要是适应证不适宜、遴选药品不适宜、老年患者用药剂量不合理、联合用药不适宜等。结论依替米星的使用存在比较严重的不合理现象,建议医院加强对依替米星临床用药的监督以及合理用药知识的培训。 Objective To promote the rational use of etimicin in clinic through prescription review.Methods Through special comments on etimicin prescriptions in outpatient and emergency departments of Beijing Water Conservancy Hospital from January to October in 2018,the rationality of clinical medication was analyzed.Results Totally 729 prescriptions of etimicin were used,of which 508 were unreasonable and the rate of unqualified prescriptions was 69.68%.The main reasons are inappropriate indications,unsuitable selection of drugs,irrational dosage for elderly patients,and inappropriate combination of drugs.Conclusion There are serious unreasonable phenomena in the use of etimicin.It is suggested that hospitals should strengthen the supervision of etimicin in clinical use and the training of rational drug use knowledge in order to improve the rationality of drug use.
作者 朱晓燕 ZHU Xiao-yan(Department of Pharmacy,Beijing Water Conservancy Hospital,Beijing 100036,China)
出处 《临床药物治疗杂志》 2019年第7期78-80,共3页 Clinical Medication Journal
关键词 依替米星 处方点评 合理用药 etimicin special comments on prescriptions rational drug use
  • 相关文献

参考文献5

二级参考文献29

  • 1邓筱华.硫酸依替米星的临床应用与安全性评价[J].中国临床药学杂志,2004,13(5):320-322. 被引量:32
  • 2李家泰,刘健,张烨,钟巍.新氨基糖苷类抗生素89—07体外抗菌作用研究[J].中国抗生素杂志,1995,20(6):407-415. 被引量:56
  • 3宋毅,唐尧,徐廷,潘晓鸥,张李华.2822例患者应用硫酸依替米星注射剂安全性分析[J].中国抗生素杂志,2006,31(1):31-32. 被引量:27
  • 4卫生部,国家中医药管理局,总后卫生部.抗茵药物临床应用指导原则[S].卫医发[2004]285号.
  • 5卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 6王宗敏,吴晓明,颜敏.构建药品不良反应监测体系之探讨[J].中国药事,2007,21(8):578-581. 被引量:15
  • 7Welage LS, Walawander CA, Timm EG, et al. Risk factors for acute renal insufficiency in patients with Suspected or documented bacterial pneumonia. Ann Pharmaco- ther. 1994 Apr,28(4) :515-22.
  • 8卫生部.2011年抗茵药物临床应用专项整治活动方案[z].卫办医政发[2011]56号.
  • 9Ansari F, Erntell M, Goossens H, et al. The European surveillance of antimicrobial consumption(ESAC) point-prevalence survey of antimicrobial agents use in 20 European hospitals in 2006[J]. Clin Infect Dis, 2009, 49(10): 1496-1504.
  • 10Thu TA, Rahman M, Coffin S, et al. Antibiotic use in Vietnamese hospitals: a multicenter point-prevalence study[J]. Am J Infect Control, 2012, 40(9): 840-844.

共引文献16

同被引文献31

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部